120 related articles for article (PubMed ID: 2717059)
1. Time course of postmortem modifications in synaptosomal [3H]dopamine uptake and [3H]GBR 12783 binding to the dopamine uptake complex in the rat striatum.
Thibaut F; Bonnet JJ; Costentin J
Neurosci Lett; 1989 Jan; 96(3):335-9. PubMed ID: 2717059
[TBL] [Abstract][Full Text] [Related]
2. Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics.
Richfield EK
Brain Res; 1991 Feb; 540(1-2):1-13. PubMed ID: 1829013
[TBL] [Abstract][Full Text] [Related]
3. Photoaffinity labeling of the dopamine reuptake carrier protein with 3-azido[3H]GBR-12935.
Berger SP; Martenson RE; Laing P; Thurkauf A; Decosta B; Rice KC; Paul SM
Mol Pharmacol; 1991 Apr; 39(4):429-35. PubMed ID: 2017146
[TBL] [Abstract][Full Text] [Related]
4. GBR 12783, a potent and selective inhibitor of dopamine uptake: biochemical studies in vivo and ex vivo.
Bonnet JJ; Costentin J
Eur J Pharmacol; 1986 Feb; 121(2):199-209. PubMed ID: 3754516
[TBL] [Abstract][Full Text] [Related]
5. In vivo labelling of the neuronal dopamine uptake complex in the mouse striatum by [3H]GBR 12783.
Vaugeois JM; Bonnet JJ; Costentin J
Eur J Pharmacol; 1992 Jan; 210(1):77-84. PubMed ID: 1350989
[TBL] [Abstract][Full Text] [Related]
6. High-affinity [3H]GBR 12783 binding to a specific site associated with the neuronal dopamine uptake complex in the central nervous system.
Bonnet JJ; Protais P; Chagraoui A; Costentin J
Eur J Pharmacol; 1986 Jul; 126(3):211-22. PubMed ID: 3489625
[TBL] [Abstract][Full Text] [Related]
7. Translocation of dopamine and binding of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl) tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Inhibition by various blockers.
Xu C; Coffey LL; Reith ME
Biochem Pharmacol; 1995 Jan; 49(3):339-50. PubMed ID: 7857321
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes.
Zhu J; Mactutus CF; Wallace DR; Booze RM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1071-83. PubMed ID: 19325033
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and pharmacological characterization of [3H]GBR 12935 binding in vitro to rat striatal membranes: labeling of the dopamine uptake complex.
Andersen PH
J Neurochem; 1987 Jun; 48(6):1887-96. PubMed ID: 2952763
[TBL] [Abstract][Full Text] [Related]
10. Consequences of an intrastriatal injection of kainic acid on the dopaminergic neuronal and vesicular uptake systems.
Naudon L; Leroux-Nicollet I; Costentin J
Brain Res; 1992 Oct; 593(1):32-8. PubMed ID: 1360863
[TBL] [Abstract][Full Text] [Related]
11. In vivo binding of [3H]GBR 12783, a selective dopamine uptake inhibitor, in mouse striatum.
Chagraoui A; Bonnet JJ; Protais P; Costentin J
Neurosci Lett; 1987 Jul; 78(2):175-9. PubMed ID: 3627558
[TBL] [Abstract][Full Text] [Related]
12. Interaction of [3H]GBR 12935 and GBR 12909 with the dopamine uptake complex in nucleus accumbens.
Berger P; Elsworth JD; Arroyo J; Roth RH
Eur J Pharmacol; 1990 Feb; 177(1-2):91-4. PubMed ID: 1967129
[TBL] [Abstract][Full Text] [Related]
13. Dopamine uptake by rat striatal synaptosomes: time- and temperature-dependent decay and protection by dithiothreitol and dopamine.
Schoemaker H; Nickolson VJ
J Neurochem; 1983 Apr; 40(4):922-8. PubMed ID: 6834052
[TBL] [Abstract][Full Text] [Related]
14. [3H]GBR 12935 binding to dopamine uptake sites: subcellular localization and reduction in Parkinson's disease and progressive supranuclear palsy.
Maloteaux JM; Vanisberg MA; Laterre C; Javoy-Agid F; Agid Y; Laduron PM
Eur J Pharmacol; 1988 Nov; 156(3):331-40. PubMed ID: 3215281
[TBL] [Abstract][Full Text] [Related]
15. Zinc modulation of drug binding, cocaine affinity states, and dopamine uptake on the dopamine uptake complex.
Richfield EK
Mol Pharmacol; 1993 Jan; 43(1):100-8. PubMed ID: 8423763
[TBL] [Abstract][Full Text] [Related]
16. Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine.
Kula NS; Baldessarini RJ
Neuropharmacology; 1991 Jan; 30(1):89-92. PubMed ID: 2046881
[TBL] [Abstract][Full Text] [Related]
17. Characterization of sodium-dependent [3H]GBR-12935 binding in brain: a radioligand for selective labelling of the dopamine transport complex.
Janowsky A; Berger P; Vocci F; Labarca R; Skolnick P; Paul SM
J Neurochem; 1986 Apr; 46(4):1272-6. PubMed ID: 3081686
[TBL] [Abstract][Full Text] [Related]
18. [3H]GBR-12935 binding to dopamine uptake sites in rat striatum.
Allard PO; Eriksson K; Ross SB; Marcusson JO
Neuropsychobiology; 1990-1991; 23(4):177-81. PubMed ID: 2130286
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the sequential formation of two complexes between an uptake inhibitor, GBR 12783 [1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-2-propenyl)piperazine], and the neuronal transporter of dopamine.
Do-Régo JC; Hue H; Costentin J; Bonnet JJ
J Neurochem; 1999 Jan; 72(1):396-404. PubMed ID: 9886093
[TBL] [Abstract][Full Text] [Related]
20. Thermodynamic analyses of the binding of substrates and uptake inhibitors on the neuronal carrier of dopamine labeled with [3H]GBR 12783 or [3H]mazindol.
Bonnet JJ; Benmansour S; Costentin J; Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1990 Jun; 253(3):1206-14. PubMed ID: 2141637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
